Journal article
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer
Abstract
Importance: Stereotactic body radiotherapy (SBRT) is widely used for stage I medically inoperable non-small cell lung cancer (NSCLC), yet varied results from randomized clinical trials (RCTs) and concerns in treating centrally located tumors persist.
Objective: To examine whether SBRT would improve local control (LC) compared with hypofractionated conventional radiotherapy (CRT).
Authors
Swaminath A; Parpia S; Wierzbicki M; Kundapur V; Faria S; Okawara GS; Tsakiridis TK; Ahmed N; Bujold A; Hirmiz K
Journal
JAMA Oncology, Vol. 10, No. 11, pp. 1571–1575
Publisher
American Medical Association (AMA)
Publication Date
November 1, 2024
DOI
10.1001/jamaoncol.2024.3089
ISSN
2374-2437